Patents Assigned to Euclid Systems Corporation
  • Device and method for the controlled delivery of ophthalmic solutions
    Patent number: 9399102
    Abstract: The present disclosure is directed to an injector device for delivering an ophthalmic solution to a cornea of an eye. The device may include a base configured to contact part of the eye, and a needle connected to the base, wherein needle may deliver the ophthalmic solution to the cornea.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: July 26, 2016
    Assignee: EUCLID SYSTEMS CORPORATION
    Inventors: Bruce H. Dewoolfson, Donald Harris, Mike Luttrell, Gabriel Carpio
  • Collagen-based implants for sustained delivery of drugs
    Patent number: 9289396
    Abstract: The disclosure provides collagen-based constructs for use in drug delivery.
    Type: Grant
    Filed: August 1, 2011
    Date of Patent: March 22, 2016
    Assignee: Euclid Systems Corporation
    Inventors: Dale P. Devore, Bruce H. Dewoolfson, Eliot Lazar
  • DRUG STORAGE AND DELIVERY DEVICE AND METHOD
    Publication number: 20130303973
    Abstract: A drug delivery device and method is disclosed. The drug delivery device may include a cutting portion configured to form a slit in a portion of eye tissue. The drug device may also include a sliding assembly configured to slide with respect to the cutting portion to deliver a biopharmaceutical device to the portion of eye tissue.
    Type: Application
    Filed: May 8, 2013
    Publication date: November 14, 2013
    Applicant: Euclid Systems Corporation
    Inventors: Bruce Dewoolfson, Michael St. John Luttrell, Thomas Kent Mundorf, Eliot Stuart Lazar
  • Composition for stabilizing corneal tissue during or after orthokeratology lens wear
    Patent number: 7402562
    Abstract: An orthokeratological procedure is provided that prevents or retards relaxation of corneal tissue back to the original anterior curvature of the cornea. The procedure comprises applying a stabilizing agent that comprises fibril associated collagens with interrupted triple helices (FACITs) and/or small leucine-rich repeat proteoglycans (SLRPs) to the stabilize corneal tissue in a preselected shape.
    Type: Grant
    Filed: June 7, 2005
    Date of Patent: July 22, 2008
    Assignees: Euclid Systems Corporation, The Bruce H. DeWoolfson Irrevocable Family Trust
    Inventors: Bruce H. DeWoolfson, Dale P. DeVore